BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/23/2016 9:36:00 PM | Browse: 527 | Download: 786
Publication Name World Journal of Diabetes
Manuscript ID 23192
Country of Manuscript Source Japan
2015-10-30 08:51
Peer-Review Started
2015-11-03 15:38
To Make the First Decision
2015-11-24 14:55
Return for Revision
2015-11-30 16:08
2015-12-13 10:36
Second Decision
2016-01-18 10:38
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2016-01-29 17:56
Articles in Press
2016-01-29 17:56
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2016-03-21 16:16
Publish the Manuscript Online
2016-03-23 21:36
ISSN 1948-9358 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Endocrinology and Metabolism
Manuscript Type Review
Article Title Low serum amylase and obesity, diabetes and metabolic syndrome: A novel interpretation
Manuscript Source Invited Manuscript
All Author List Kei Nakajima
Funding Agency and Grant Number
Corresponding author Kei Nakajima, MD, PhD, Department of Metabolism, Kuki General Hospital, 418-1 Kamihayami, Kuki, Saitama 346-8530, Japan. keinaka@josai.ac.jp
Keywords Serum amylase; Salivary; Pancreas; Diabetes; Metabolic syndrome; Obesity; AMY1; AMY2; Insulin resistance
Core Tip Low serum amylase was believed to occur in uncommon conditions such as type 1 diabetes, advanced chronic pancreatitis, and cystic fibrosis. However, in the last decade, low serum amylase has been observed in more common conditions related with insulin resistance than was previously believed. In this review, a novel interpretation for low serum, salivary, and pancreatic amylase is discussed, particularly in terms of the cardiometabolic conditions of obesity, diabetes, and metabolic syndrome.
Publish Date 2016-03-23 21:36
Citation Nakajima K. Low serum amylase and obesity, diabetes and metabolic syndrome: A novel interpretation. World J Diabetes 2016; 7(6): 112-121
Url http://www.wjgnet.com/1948-9358/full/v7/i6/112.htm
DOI http://dx.doi.org/10.4239/wjd.v7.i6.112
Full Article (PDF) WJD-7-112.pdf
Full Article (Word) WJD-7-112.doc
Manuscript File 23192-Review.doc
Answering Reviewers 23192-Answering reviewers.pdf
Audio Core Tip 23192-Audio core tip .mp3
Conflict-of-Interest Disclosure Form 23192-Conflict-of-interest statement.pdf
Copyright License Agreement 23192-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 23192-Language certificate.pdf
Peer-review Report 23192-Peer-review(s).pdf
Scientific Misconduct Check 23192-Scientific misconduct check.pdf
Scientific Editor Work List 23192-Scientific editor work list.pdf